Summary of home kits received and completed tests by indication for faecal calprotectin
| Flaring | Surveillance | Response to therapy | New Diagnosis | All | |
| IBDoc kit recipients, n (%) | 10 (100) | 22 (100) | 20 (100) | 2 (100) | 54 (100) |
| Kits posted, n (%) | 9 (90) | 22 (100) | 13 (65) | 0 (0) | 44 (81) |
| Kits face-to-face, n (%) | 1 (10) | 0 (0) | 7 (35) | 2 (100) | 10 (19) |
| IBDoc result, n (%) | 6 (60) | 17 (77) | 14 (70) | 2 (100) | 41 (76) |
| IBDoc result only, n (%) | 4 (40) | 14 (64) | 8 (40) | 0 (0) | 26 (48) |
| Lab result only, n (%) | 4 (40) | 2 (9) | 2 (10) | 0 (0) | 8 (14.8) |
| IBDoc + lab result, n (%) | 3 (40) | 3 (14) | 6 (30) | 2 (100) | 14 (26) |
| No result, n (%) | 0 (0) | 3 (14) | 4 (20) | 0 (0) | 6 (11) |
| Repeat IBDoc test | 1 (10) | 0 | 2 (10) | 1 (50) | 4 (7)* |
*One repeated for invalid result, three as part of continued monitoring.
n, number of patients.